21/03/2024, Paris, France ERINHA (European Research Infrastructure on Highly Pathogenic Agents) spearheads the EU-funded NAVIPP (New AntiVirals for Infections with Pandemic Potential) project, an ambitious endeavour aimed at fortifying the European Union’s preparedness and response capabilities against viral threats with pandemic potential. NAVIPP represents a collaborative effort among esteemed international research institutions, pharmaceutical entities, and […]